Annexon Inc.

07/22/2021 | Press release | Distributed by Public on 07/22/2021 14:16

Annexon Broadens Autoimmune Franchise with Advancement of Third Anti-C1q Product Candidate and Strategic Expansion into New Autoantibody-driven Diseases (Form 8-K)